| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b88d3bc25a6c3f27d97bc6d67b46b1ab |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
| filingDate |
2000-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fb1e78da6c8ed9a635ae74615ae61c8 |
| publicationDate |
2002-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-PA01009817-A |
| titleOfInvention |
ORAL PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN LONG-CHAIN TRIGLICERIDS AND LIPOFILIC TENSIOACTIVE. |
| abstract |
The invention described herein relates to liquid pharmaceutical compositions for oral administration which contain a drug an active ingredient dissolved in a liquid vehicle or carrier in which the liquid vehicle comprises a glyceride of a long chain fatty acid having 14 to 22 carbon atoms and a lipophilic surfactant having an EHL of less than 10. The compositions of the invention provide increased stability of the drug or active ingredient and contain a liquid vehicle which is less reactive with the drug or active ingredient than free fatty acids. In one embodiment, liquid pharmaceutical compositions contain testosterone undecanoate, a long chain triglyceride, a lauroglycol. The compositions can be administered orally and formulated as a soft gel capsule or hard shell. |
| priorityDate |
1999-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |